NS
Narasimman Suresh
About Narasimman Suresh
Data last updated:
Narasimman Suresh is a Managing Director at Medigrand Pharmaceuticals Private Limited (since 2022). The companies operate in Pharma. Medigrand Pharmaceuticals Private Limited reported revenue of ₹1.34 Cr (FY 2022). Earlier, Narasimman Suresh was a Director at Blured Pharmaceuticals Private Limited (2021–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medigrand Pharmaceuticals Private Limited U24297TN2011PTC081348 | Managing Director | 06 Jul 2022 | 2011 | ₹1.34 Cr (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Blured Pharmaceuticals Private Limited U24100TN2015PTC101840 | Director | 30 Sep 2021 | 2015 | ₹2.87 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narasimman Suresh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ayyakannu Sivakumar | 07217283 | Medigrand Pharmaceuticals Private Limited | Director |
| Muthamilan Vivekanandhan | 09425024 | Medigrand Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narasimman Suresh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narasimman Suresh
Narasimman Suresh currently holds 1 directorship: Medigrand Pharmaceuticals Private Limited (Managing Director, since 06 Jul 2022, revenue ₹1.34 Cr (FY 2022)).
Narasimman Suresh was first appointed on 30 Sep 2021 as Director at Blured Pharmaceuticals Private Limited. The most recent appointment on record is 06 Jul 2022 at Medigrand Pharmaceuticals Private Limited.
Narasimman Suresh held 1 earlier board appointment: Blured Pharmaceuticals Private Limited (Director, 30 Sep 2021 to 20 Mar 2024).
The current boards of Narasimman Suresh's companies include Ayyakannu Sivakumar (Medigrand Pharmaceuticals Private Limited), Muthamilan Vivekanandhan (Medigrand Pharmaceuticals Private Limited).